Amrutanjan Healthcare

BSE : 590006 | NSE : AMRUTANJAN

Industry : Pharma Formulations | ISIN : INE098F01031 | FreeFloat : 50.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)1,043.86
Net Worth (NW)265.12
Intrinsic Worth (IW)1,308.98
Market Cap (MC)2,322.67
Economic Value Added5.20
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)79.75%
IC Gross Margin (EBITDA/IC)11.34%
IC Net Margin (NPT/IC)7.90%
Knowledge Turnover (Sales/IC)0.44
Market to Intrinsic Value (MC/IW)1.77

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 447.81Rs. 794.60
8 Aug 2022 ---- Rs. 828.50
14.70     1.77%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 802.91BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 796.05
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
S
44.60
46.15
-1.56
-0.85
-0.91
-0.70
-0.70
Sep-19
S
74.81
76.67
11.58
12.17
12.12
8.40
8.40
Dec-19
S
82.75
85.01
11.60
12.65
12.60
9.49
9.49
Mar-20
S
59.32
61.96
11.73
10.71
10.64
7.89
7.89
Jun-20
S
46.62
48.66
9.65
8.71
8.66
6.43
6.40
Sep-20
S
92.11
96.16
32.32
31.43
31.39
23.55
23.72
Dec-20
S
100.10
102.64
29.03
28.19
28.14
20.99
20.77
Mar-21
S
94.02
96.70
15.07
14.08
13.71
10.23
10.28
Jun-21
S
78.21
80.95
17.29
16.37
16.29
12.06
12.03
Sep-21
S
110.38
114.67
27.23
26.43
26.36
19.85
19.45
Dec-21
S
110.70
113.89
28.82
27.94
27.92
20.58
20.34
Mar-22
S
106.55
111.71
21.51
20.32
20.02
14.71
14.71
* C - Consolidated, S - Standalone